FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Sanofi-Aventis U.S. Admelog Solostar Recall

Admelog Solostar (insulin lispro injection), 100 units/ mL (U-100) injection, packaged…

Sanofi-Aventis U.S. LLC · Bridgewater, NJ

Risk level
Class II
Reported by FDA
Jul 18, 2018
Recall ID
D-0925-2018
Check your lot numberHow we source this data

Summary

Sanofi-Aventis U.S. recalled Admelog Solostar starting Jul 5, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0925-2018 on Jul 18, 2018. Reason: Temperature Abuse: Product samples of Admelog may not have been shipped at proper temperature. Status: Ongoing.

Why it was recalled

Temperature Abuse: Product samples of Admelog may not have been shipped at proper temperature.

Product description

Admelog Solostar (insulin lispro injection), 100 units/ mL (U-100) injection, packaged in 3mL prefilled pens, 1 pen per box, Rx only, Physician Sample - Not For Sale, Sanofi-Aventis U.S. LLC, Bridgewater, NJ 08807, NDC 0024-5925-00

Lot numbers, UPCs & expiration codes

Lot #: 7F021B, Exp 6/30/20

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0925-2018
Classification
Class II
Status
Ongoing
Recall initiated
Jul 5, 2018
FDA report date
Jul 18, 2018
Quantity
3214 prefilled pens
Recall type
Voluntary: Firm initiated
Recalling firm
Sanofi-Aventis U.S. LLC

Original FDA data

Every field from FDA enforcement report D-0925-2018, exactly as published.

Show all FDA fields
City
Bridgewater
State
NJ
Status
Ongoing
Country
United States
Event ID
80387
Address
55 Corporate Dr
Code information
Lot #: 7F021B, Exp 6/30/20
Postal code
08807-1265
Report date
Jul 18, 2018
Product type
Drugs
Recall number
D-0925-2018
Classification
Class II
Recalling firm
Sanofi-Aventis U.S. LLC
Product quantity
3214 prefilled pens
Reason for recall
Temperature Abuse: Product samples of Admelog may not have been shipped at proper temperature.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Admelog Solostar (insulin lispro injection), 100 units/ mL (U-100) injection, packaged in 3mL prefilled pens, 1 pen per box, Rx only, Physician Sample - Not For Sale, Sanofi-Aventis U.S. LLC, Bridgewater, NJ 08807, NDC 0024-5925-00
Distribution pattern
Nationwide
Recall initiation date
Jul 5, 2018
Initial firm notification
Letter
Center classification date
Jul 16, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0925-2018, published Jul 18, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls